Consolidated Statement of Recognised Income and Expense
for the years ended 31 March
| Note | 2008 £m |
2007 £m |
2006 £m |
|
|---|---|---|---|---|
| Gains on revaluation of available-for-sale investments, net of tax | 22 | 1,949 | 2,108 | 705 |
| Exchange differences on translation of foreign operations, net of tax | 22 | 5,537 | (3,804) | 1,494 |
| Net actuarial (losses)/gains on defined benefit pension schemes, net of tax | 22 | (37) | 50 | (30) |
| Revaluation gain | 22 | – | – | 112 |
| Foreign exchange (gains)/losses transferred to the Consolidated Income Statement | 22 | (7) | 838 | 36 |
| Fair value gains transferred to the Consolidated Income Statement | 22 | (570) | – | – |
| Other | 22 | 37 | – | – |
| Net gain/(loss) recognised directly in equity | 6,909 | (808) | 2,317 | |
| Profit/(loss) for the financial year | 6,756 | (5,297) | (21,821) | |
| Total recognised income and expense relating to the year | 13,665 | (6,105) | (19,504) | |
| Attributable to: | ||||
| – Equity shareholders | 13,912 | (6,210) | (19,607) | |
| – Minority interests | (247) | 105 | 103 | |
| 13,665 | (6,105) | (19,504) |
The accompanying notes are an integral part of these Consolidated Financial Statements.